J Am Acad Child Adolesc Psychiatry 2008; 47; 920. 17. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

J Child Adolesc Psychopharmacol 2010; 20; 415-22.

Aparasu RR, Bhatara V.

Patterns and determinants of antipsychotic prescribing in children and adolescents, 20032004.

Curr Med Res Opin 2007; 23; 4956.

Bachmann CJ, Lehr D, Theisen FM, Preiss M.

Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.

Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent.

The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.

J Child Adolesc Psychopharmacol 2004; 14; 593-600.

Bastiaens L. A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.

Community Ment. Health J 2009; 45; 7377.

Bat-Pitault F, Delorme R.

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.

Schizophr Bull 2011; 37 Suppl 2; S111-21.

Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, Mick E.

Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.

CNS Spectr 2005; 10; 141-8.

Biederman J, Mick E, Spencer T, Doyle R, Joshi G, Hammerness P, Kotarski M, Aleardi M, Wozniak J.

An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.

CNS Spectr 2007; 12; 683-9.

Budman C, Coffey BJ, Shechter R, Schrock M, Wieland N, Spirgel A, Simon E.

Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.

J Child Adolesc Psychopharmacol 2008; 18; 509-15.

Carmel H, Gorman JM.

Classifying antipsychotics by likelihood of metabolic side-effects.

Effectiveness and safety of antipsychotics in early onset psychoses: a longterm comparison.

Psychiatry Res 2011; 189; 349- 56.

Cohen J, Magalon D, Boyer L, Simon N, Christophe L.

Aripiprazole-induced pathological gambling: a report of 3 cases.

Curr Drug Saf 2011; 6; 51-3.

Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK.

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

J Am Acad Child Adolesc Psychiatry 2008; 47; 920.

Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.

Psiquiatria General Goldman Pdf